rs727502824
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PM4_SupportingPP5_Very_Strong
The NM_001875.5(CPS1):c.3037_3039delGTG(p.Val1013del) variant causes a conservative inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,720 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. V1013V) has been classified as Likely benign.
Frequency
Consequence
NM_001875.5 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- carbamoyl phosphate synthetase I deficiency diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CPS1 | NM_001875.5 | c.3037_3039delGTG | p.Val1013del | conservative_inframe_deletion | Exon 25 of 38 | ENST00000233072.10 | NP_001866.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461720Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 727152 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Congenital hyperammonemia, type I Pathogenic:3
- -
For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (ExAC no frequency). This variant has been reported to affect CPS1 protein function (PMID: 25410056). This variant has been observed in individual(s) with carbamoyl phosphate synthetase I deficiency (PMID: 25410056, 12655559, 22575620). This variant is also known as c.3036_3038delGGT in the literature. ClinVar contains an entry for this variant (Variation ID: 162525). This variant, c.3037_3039del, results in the deletion of 1 amino acid(s) of the CPS1 protein (p.Val1013del), but otherwise preserves the integrity of the reading frame. -
Variant summary: CPS1 c.3037_3039delGTG (p.Val1013del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant was absent in 251346 control chromosomes. c.3037_3039delGTG has been reported in the literature in multiple individuals affected with Carbamoylphosphate Synthetase I Deficiency (example: Hu_2014). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity (Hu_2014). The following publication has been ascertained in the context of this evaluation (PMID: 25410056). ClinVar contains an entry for this variant (Variation ID: 162525). Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at